MicroRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2018 Dec 23

PMID 30577536

Citations 50

Authors

Ning Wang

Hor-Yue Tan

Yi-Gang Feng

Cheng Zhang

Feiyu Chen

Yibin Feng

Affiliations

Soon will be listed here.

Abstract

microRNA-23a (miR-23a) is one of the most extensively studied miRNAs in different types of human cancer, and plays various roles in the initiation, progression, and treatment of tumors. Here, we comprehensively summarize and discuss the recent findings about the role of miR-23a in cancer. The differential expression of tissue miR-23a was reported, potentially indicating cancer stages, angiogenesis, and metastasis. miR-23a in human biofluid, such as plasma and salivary fluid, may be a sensitive and specific marker for early diagnosis of cancer. Tissue and circulating miR-23a serves as a prognostic factor for cancer patient survival, as well as a predictive factor for response to anti-tumor treatment. The direct and indirect regulation of miR-23a on multiple gene expression and signaling transduction mediates carcinogenesis, tumor proliferation, survival, cell migration and invasion, as well as the response to anti-tumor treatment. Tumor cell-derived miR-23a regulates the microenvironment of human cancer through manipulating both immune function and tumor vascular development. Several transcriptional and epigenetic factors may contribute to the dysregulation of miR-23a in cancer. This evidence highlights the essential role of miR-23a in the application of cancer diagnosis, prognosis, and treatment.

Citing Articles

The 4EHP-mediated translational repression of cGAS impedes the host immune response against DNA viruses.

Ladak R, Choi J, Luo J, Chen O, Mahmood N, He A Proc Natl Acad Sci U S A. 2024; 121(48):e2413018121.

PMID: 39560640 PMC: 11621783. DOI: 10.1073/pnas.2413018121.

Macrophage extracellular vesicle-packaged miR-23a-3p impairs maintenance and angiogenic capacity of human endothelial progenitor cells in neonatal hyperoxia-induced lung injury.

Wang X, Yao F, Yang L, Han D, Zeng Y, Huang Z Stem Cell Res Ther. 2024; 15(1):295.

PMID: 39256862 PMC: 11389047. DOI: 10.1186/s13287-024-03920-z.

miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses.

Toropko M, Chuvpilo S, Karabelsky A Pharmaceutics. 2024; 16(8).

PMID: 39204331 PMC: 11360794. DOI: 10.3390/pharmaceutics16080986.

miRNA Profiles in Patients with Hematological Malignancy at Different Stages of the Disease: A Preliminary Study.

Hashem J, Alkhalaileh L, Abushukair H, Ayesh M Biomedicines. 2024; 12(8).

PMID: 39200388 PMC: 11351647. DOI: 10.3390/biomedicines12081924.

Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation of FOXM1 expression.

Liang L, Cai T, Li X, An J, Yu S, Zhang Y Genes Dis. 2024; 11(5):101203.

PMID: 39022126 PMC: 11252794. DOI: 10.1016/j.gendis.2023.101203.

References

Takahashi H, Ishii H, Nishida N, Takemasa I, Mizushima T, Ikeda M . Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Ann Surg Oncol. 2010; 18(4):1166-74. DOI: 10.1245/s10434-010-1373-9. View

Wang G, Li B, Fu Y, He M, Wang J, Shen P . miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1. Tumour Biol. 2015; 36(6):4715-21. DOI: 10.1007/s13277-015-3120-0. View

Zheng H, Li W, Wang Y, Xie T, Cai Y, Wang Z . miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer. Carcinogenesis. 2013; 35(1):173-83. DOI: 10.1093/carcin/bgt274. View

Cao M, Seike M, Soeno C, Mizutani H, Kitamura K, Minegishi Y . MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. Int J Oncol. 2012; 41(3):869-75. PMC: 3582905. DOI: 10.3892/ijo.2012.1535. View

Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F . Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer. 2012; 132(1):116-27. DOI: 10.1002/ijc.27657. View

Cheng Y, Kirschner M, Cheng N, Gattani S, Klebe S, Edelman J . ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma. J Thorac Oncol. 2014; 8(10):1317-28. DOI: 10.1097/JTO.0b013e3182a0840a. View

Saito A, Suzuki H, Horie M, Ohshima M, Morishita Y, Abiko Y . An integrated expression profiling reveals target genes of TGF-β and TNF-α possibly mediated by microRNAs in lung cancer cells. PLoS One. 2013; 8(2):e56587. PMC: 3577886. DOI: 10.1371/journal.pone.0056587. View

Mei Y, Si J, Wang Y, Huang Z, Zhu H, Feng S . Long Noncoding RNA GAS5 Suppresses Tumorigenesis by Inhibiting miR-23a Expression in Non-Small Cell Lung Cancer. Oncol Res. 2017; 25(6):1027-1037. PMC: 7841035. DOI: 10.3727/096504016X14822800040451. View

Komatsu S, Ichikawa D, Kawaguchi T, Takeshita H, Miyamae M, Ohashi T . Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma. Oncotarget. 2016; 7(38):62034-62048. PMC: 5308709. DOI: 10.18632/oncotarget.11500. View

10.

Rathore M, Saumet A, Rossi J, de Bettignies C, Tempe D, Lecellier C . The NF-κB member p65 controls glutamine metabolism through miR-23a. Int J Biochem Cell Biol. 2012; 44(9):1448-56. DOI: 10.1016/j.biocel.2012.05.011. View

11.

Hatzl S, Geiger O, Kuepper M, Caraffini V, Seime T, Furlan T . Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP. Cancer Res. 2016; 76(12):3644-54. PMC: 5024755. DOI: 10.1158/0008-5472.CAN-15-3049. View

12.

Tang H, Deng M, Liao Q, Zeng X, Zhou X, Su Q . [Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma]. Zhonghua Bing Li Xue Za Zhi. 2012; 41(1):28-32. View

13.

Wu Q, Lu Z, Li H, Lu J, Guo L, Ge Q . Next-generation sequencing of microRNAs for breast cancer detection. J Biomed Biotechnol. 2011; 2011:597145. PMC: 3118289. DOI: 10.1155/2011/597145. View

14.

Chen P, He Y, Huang X, Tao S, Wang X, Yan H . modulates s-mediated autophagy in human luminal breast cancer cell lines. Oncotarget. 2017; 8(46):80709-80721. PMC: 5655233. DOI: 10.18632/oncotarget.21080. View

15.

Ortega M, Bouamar H . Guidelines on Designing MicroRNA Sponges: From Construction to Stable Cell Line. Methods Mol Biol. 2016; 1509:221-233. DOI: 10.1007/978-1-4939-6524-3_20. View

16.

Saumet A, Vetter G, Bouttier M, Antoine E, Roubert C, Orsetti B . Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cells. Mol Biosyst. 2012; 8(12):3242-53. DOI: 10.1039/c2mb25298h. View

17.

Tian K, Di R, Wang L . MicroRNA-23a enhances migration and invasion through PTEN in osteosarcoma. Cancer Gene Ther. 2015; 22(7):351-9. DOI: 10.1038/cgt.2015.27. View

18.

Aghaee-Bakhtiari S, Arefian E, Naderi M, Noorbakhsh F, Nodouzi V, Asgari M . MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches. Tumour Biol. 2015; 36(6):4203-12. DOI: 10.1007/s13277-015-3057-3. View

19.

Huang S, He X, Ding J, Liang L, Zhao Y, Zhang Z . Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer. 2008; 123(4):972-8. DOI: 10.1002/ijc.23580. View

20.

Huang F, Wong D, Seto W, Lai C, Yuen M . Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer development. Oncotarget. 2015; 6(33):34941-52. PMC: 4741500. DOI: 10.18632/oncotarget.5472. View